But could a project on the scale of curing primary liver cancer caused by Hepatitis B truly be accomplished by Wu Ting founding a company all on his own?
Xie Bin, of course, didn't believe Wu Ting had that kind of courage and capability. He did, however, admire Jin Yihong and her daughter for proposing such a partnership model.
In the conference room, Xie Bin, Deng Feifei, and the other two representatives waited for Wu Ting's final decision.
Wu Ting looked at Deng Feifei's proposal and began to weigh his options. 'Based on my current results, my phase-four theory is more or less complete. The only thing missing is the phase-three research and development for the new drug, Fengmu Tiada.'
'To start, the results from phases one, two, and four, along with Wu's Umbilical Knife and the core methodology for the perfect triple-combination adjuvant technology, are enough to support a startup company.'
